Clinical Trial Update: Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage [Phase 3]

View source ↗

Summary

Phase 3 trial update on oral dydrogesterone for women with recurrent miscarriage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage

Drugs mentioned

• Dydrogesterone (dydrogesterone)

Snippet

Sponsor: Abbott Products | Conditions: Recurrent Miscarriage | Phase 3 | Status: COMPLETED